Elevated expression was significantly associated with poor clinical outcomes.<h4>Conclusions</h4>Phosphorylated TOP1, TOP2A, TOP2B, and C1orf35 are strongly associated with HCC progression and poor prognosis, highlighting their potential as prognostic biomarkers and therapeutic targets. Here, TOP2A is linked to hepatocellular carcinoma.